StockData
Processa Pharmaceuticals, Inc. logo

Processa Pharmaceuticals, Inc. (PCSA) stock

PCSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$1.73+0.01 (+0.58%)

Close on Nov 17, 2026Market cap $4.83MP/E –Yield –

Processa Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Processa Pharmaceuticals's market cap was $5.22M on Nov 11, 2026, against $13.69M a year earlier. Over the last 5 years it ranged from $954.56K to $76.44M, with a median of $6.34M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$5.22M-14.2%
2025Dec 31, 2025$6.09M+110.9%
2024Dec 31, 2024$2.89M-65.0%
2023Dec 29, 2023$8.24M-52.9%
2022Dec 30, 2022$17.48M-77.1%
2021Dec 31, 2021$76.44M+101.0%
2020Dec 31, 2020$38.02M-61.5%
2019Dec 31, 2019$98.76M-29.1%
2018Dec 31, 2018$139.23M-51.9%
2017Dec 29, 2017$289.70M+463.5%
2016Dec 30, 2016$51.41M-37.5%
2015Dec 31, 2015$82.26M-76.2%
2014Dec 31, 2014$346.36M–

More Processa Pharmaceuticals figures

See a number that looks wrong?